Date published: 2026-5-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

Adaphostin (CAS 241127-58-2)

0.0(0)
Write a reviewAsk a question

Alternate Names:
NSC 680410
Application:
Adaphostin is a Bcr-Abl (the fusion protein of Bcr and c-Abl) tyrosine kinase inhibitor
CAS Number:
241127-58-2
Molecular Weight:
393.48
Molecular Formula:
C24H27NO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Available in US only.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Adaphostin is a Bcr/Abl tyrosine kinase inhibitor (IC50 = 14 μM). Adaphostin induces apoptosis in T-lymphoblastic human leukemia cell lines (IC50 values range from 16.8 to 216.3 nM) in vitro. Adaphostin has been shown to display selectivity for chronic myelogenous leukemia (CML) myeloid progenitors in vitro.


Adaphostin (CAS 241127-58-2) References

Svingen et al (2000) Effects of the bcl/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro. Clin.Cancer Res. 6 237. Avramis et al (2002) In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines. Cancer Chemother.Pharmacol. 50 479. Mow et al (2002) Effects of bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. Blood 99 664.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Adaphostin, 10 mg

sc-291833
10 mg
$129.00
US: Only available in the US

Adaphostin, 50 mg

sc-291833A
50 mg
$560.00
US: Only available in the US